TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

THEO-24

THEOPHYLLINE
Respiratory Approved 1983-08-22
1
Indication
--
Phase 3 Trials
42
Years on Market

Details

Status
Prescription
First Approved
1983-08-22
Routes
ORAL
Dosage Forms
CAPSULE, EXTENDED RELEASE

Companies

Active Ingredient: THEOPHYLLINE

THEO-24 Approval History

Loading approval history...

What THEO-24 Treats

4 indications

THEO-24 is approved for 4 conditions since its original approval in 1983. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Asthma
  • Emphysema
  • Chronic Bronchitis
  • Chronic Lung Disease
Source: FDA Label

Drugs Similar to THEO-24

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

BREYNA
BUDESONIDE
3 shared
Viatris
Shared indications:
AsthmaChronic BronchitisEmphysema
SYMBICORT
BUDESONIDE
3 shared
AstraZeneca
Shared indications:
AsthmaChronic BronchitisEmphysema
WIXELA INHUB
FLUTICASONE PROPIONATE
3 shared
Viatris
Shared indications:
AsthmaChronic BronchitisEmphysema
ARFORMOTEROL TARTRATE
ARFORMOTEROL TARTRATE
2 shared
Cipla
Shared indications:
Chronic BronchitisEmphysema
ATROVENT HFA
IPRATROPIUM BROMIDE
2 shared
Boehringer Ingelheim
Shared indications:
Chronic BronchitisEmphysema
FORMOTEROL FUMARATE
FORMOTEROL FUMARATE
2 shared
Teva
Shared indications:
Chronic BronchitisEmphysema
PERFOROMIST
FORMOTEROL FUMARATE
2 shared
Viatris
Shared indications:
Chronic BronchitisEmphysema
SPIRIVA
TIOTROPIUM BROMIDE
2 shared
Boehringer Ingelheim
Shared indications:
Chronic BronchitisEmphysema
STIOLTO RESPIMAT
OLODATEROL HYDROCHLORIDE
2 shared
Boehringer Ingelheim
Shared indications:
Chronic BronchitisEmphysema
STRIVERDI RESPIMAT
OLODATEROL HYDROCHLORIDE
2 shared
Boehringer Ingelheim
Shared indications:
Chronic BronchitisEmphysema
TERBUTALINE SULFATE
TERBUTALINE SULFATE
2 shared
LANNETT CO INC
Shared indications:
AsthmaEmphysema
TIOTROPIUM BROMIDE
TIOTROPIUM BROMIDE
2 shared
Lupin
Shared indications:
Chronic BronchitisEmphysema
ACCOLATE
ZAFIRLUKAST
1 shared
STRIDES PHARMA INTL
Shared indications:
Asthma
ADVAIR HFA
FLUTICASONE PROPIONATE
1 shared
GSK
Shared indications:
Asthma
AIRDUO RESPICLICK
FLUTICASONE PROPIONATE
1 shared
Teva
Shared indications:
Asthma
AIRSUPRA
ALBUTEROL SULFATE
1 shared
AstraZeneca
Shared indications:
Asthma
ALVESCO
CICLESONIDE
1 shared
COVIS
Shared indications:
Asthma
ARNUITY ELLIPTA
FLUTICASONE FUROATE
1 shared
GSK
Shared indications:
Asthma
ASMANEX HFA
MOMETASONE FUROATE
1 shared
Merck
Shared indications:
Asthma
BECLOMETHASONE DIPROPIONATE
BECLOMETHASONE DIPROPIONATE
1 shared
AMNEAL IRELAND LTD
Shared indications:
Asthma
πŸ”¬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
πŸ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

THEO-24 FDA Label Details

Pro

Indications & Usage

Theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.